The National Customs Brokers & Forwarders Association of America said the FDA needs to address a few remaining issues in its recently issued guidance document on upcoming cosmetics registration and product listing requirements.
On Jan. 18, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Jan. 17, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Jan. 16, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
A scheduled FDA upgrade of its import operations database will lead to an outage from 10 p.m. Jan. 20 to 5 a.m. Jan. 21 EST, CBP said Jan. 17. This will affect the Interoperability Web Service (IWS), the FDA Import Trade Auxiliary Communications Systems (ITACS) and prior notice applications, except the Prior Notice System Interface (PNSI), the agency said in a CSMS message.
The FDA posted a document showing the information needed "for successful filing of Electronic Nicotine Delivery System (ENDS) products," CBP said in a CSMS message Jan. 17. The information needs to be provided to the customs broker on the shipment in order to avoid a delay of an FDA admissibility determination, CBP said. "*Please share this resource with your customs broker," the FDA said.
On Jan. 12, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Jan. 10, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Jan. 9, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The FDA is proposing to end the use of four chemical solvents under its color additive regulations, it said in a pair of notices released Jan. 10. In one notice, the agency said that it filed a petition to remove provisions from the regulations for ethylene dichloride, methylene chloride and trichloroethylene. In the other, the FDA said it filed a petition to remove benzene, as well as other uses of ethylene dichloride, methylene chloride and trichloroethylene. The petitions say the chemicals have been found to cause cancer. Comments are due March 11.